COVID concerns: Immunosuppression does not hinder COVID-19 outcomes
Kayte Andersen, MSc, and G. Caleb Alexander, MD, MS, with John Jesitus According to a recent study, clinical outcomes for chronically immunosuppressed patients hospitalized with COVID-19 mirror those of non-immunosuppressed peers. The analysis included immunosuppressive medications commonly used in dermatology. When the COVID-19 pandemic began, said first author Kayte Andersen, MSc, it was uncertain whether […]
Diagnose this zebra: A differential diagnosis case
A drug-induced bullous eruption with a twist Matthew J. Zirwas, MD, with Cheryl Guttman Krader CASE HISTORY A 40-year-old white man presented with a 2-week history of widespread blisters. Clinical examination showed tense, subepidermal-appearing bullae on mildly erythematous bases (Figure 1). Palms, soles, scalp, and mucous membranes were all spared. On history, the patient reported […]